Rossman, M.D., Thompson, B., Fredrick, M., Iannuzzi, M.C., Rybicki, B.A., Pandey, J.P., Newman, L.S., Rose, C., Magira, E., Monos, D., ACCESS Group. HLA and environmental interactions in sarcoidosis. Sarcoid Vasc Diff Lung Dis 2008 25:125-32.
Mroz, M.M., Maier, L.A., Strand, M., Silviera, L., Newman, L.S. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Indust Med 2009 52:762-73.
Dobis, D.R., Sawyer, R.T., Gillespie, M.M., Newman, L.S., Maier, L.A., Day, B.J. Sulfasalazine and Mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol 2009 (Epub ahead of print).
Oswald-Richter, K., Sato, H., Hajizadeh, R., Shepherd, B.E., Sidney, J., Sette, A., Newman, L.S., Drake, W.P. Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele DRB1*1101. J Clin Immunol 2010:157-66.
Sato, H., Silveira, L., Spagnolo, P., Gillespie, M., Gottschall, E.B., Welsh, K.I., du Bois, R.M., Newman, L.S., Maier, L.A. C-C chemokine receptor 5 (CCR5) polymorphisms in beryllium disease. Eur Respir J 2010 (Epub ahead of print).
Weaver, D.R., Newman, L.S., Lezotte, D.C., Morley, P.S. Perceptions regarding workplace hazards at a veterinary referral and teaching hospital. J Am Vet Med Assoc 2009 (in press).